Treatment of patent ductus arteriosus: Indomethacin or ibuprofen?

Journal of Perinatology

Volumn 28, Issue , 2008, Pages S60-S62

  Sekar, K C ^a   Corff, K E ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Ibuprofen; Indomethacin; Patent ductus arteriosus; Prematurity

Indexed keywords

ALBUMIN; BILIRUBIN; IBUPROFEN; IBUPROFEN LYSINE; INDOMETACIN; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTERY LIGATION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; COMPETITIVE INHIBITION; CONFERENCE PAPER; DRUG APPROVAL; DRUG CHOICE; DRUG EFFICACY; DRUG ELIMINATION; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG USE; HEMODYNAMICS; HUMAN; INFANT; KIDNEY BLOOD FLOW; NEWBORN MORBIDITY; PATENT DUCTUS ARTERIOSUS; PERSISTENT PULMONARY HYPERTENSION; PREMATURITY; PROPHYLAXIS; PROSTAGLANDIN SYNTHESIS INHIBITION; TREATMENT FAILURE; TREATMENT RESPONSE; UNITED STATES;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; LYSINE;

EID: 43049116155     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.52     Document Type: Article

References (35)

1. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate 2006; 89: 330–335.
2. Cardiac abnormalities. In:Gomella TL, Cunningham MD, Eyal FG (eds). Neonatology: Management, Procedures, On-Call Problems, Diseases, and Drugs. 4th edn. Appleton & Lange: Stamford, CT, 1999 pp 335–352.
3. Bancalari E, Claure N, Ganzalez A. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 2005; 88: 192–201.
4. Cotton RB, Stahlman MT, Dovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr 1979; 2: 467–473.
5. Corff KE, Sekar KC. Clinical considerations for the pharmacological management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants. J Pediatr Pharmacol Ther 2007; 12: 147–157.
6. Evans N, Malcolm G, Osborn D, Kluckow M. Diagnosis of patent ductus arteriosus in preterm infants. Neonatal Rev 2004; 5: e86–e97.
7. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674–681.
8. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006; 26: S14–S18.
9. Clyman RI, Chorne N. Patent ductus arteriosus: evidence for and against treatment. J Pediatr 2007; 150: 216–219.
10. Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med 2000; 343: 728–729.
11. Kabra NS, Schmidt B, Roberts S, Doyle LW, Papile L, Fanaroof A et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. J Pediatr 2007; 150: 229–234.
12. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 1997; 76: F179–F184.
13. Yaffe, Aranda eds. Neonatal and Pediatric Pharmacology, 3rd edn. 2005 p 670.
14. Grosfeld JL, Kamman K, Gross K, Cikrit D, Ross D, Wolfe M et al. Comparative effects of indomethacin, prostaglandin E1, and ibuprofen on bowel ischemia. J Pediatr Surg 1983; 18: 738–742.
15. Yaffe, Aranda eds. Neonatal and Pediatric Pharmacology, 3rd edn. 2005; pp 671–675.
16. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131: 549–554.
17. McCormick DC, Edwards AD, Brown GC, Wyatt JS, Potter A, Cope M et al. Effect of indomethacin on cerebral oxidized cytochrome oxidase in preterm infants. Pediatr Res 1993; 33: 603–608.
18. Fowlie PW, Davis PG. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD000174.
19. Shah SS, Ohlsson A. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004213.
20. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999; 135: 733–738.
21. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674–681.
22. Ohlsson A, Walia R, Shah S. The Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.:CD003481.
23. Shah SS, Ohlsson A. The Cochrane Database of Systematic Reviews 2006, Issue 1.Art. No.: CD004213.
24. Koehne PS, Helfenstein D, Pees C, Walch E, Obladen M. Neurodevelopmental outcome of very low birth weight infants after intervention for patent ductus arteriosus with cyclooxygenase inhibitors. EPAS 2007; 615911: 14.
25. Ahlfors CE. Effect of ibuprofen on bilirubin–albumin binding. J Pediatr 2004; 144(3): 386–388.
26. Cooper-Peel C, Brodersen R, Robertson A. Does ibuprofen affect bilirubin–albumin binding in the newborn infant serum? Pharmacol Toxicol 1996; 79(6): 297–299.
27. Gourney V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomized, double-blind, placebo-controlled trial. Lancet 2004; 364: 1939–1944.
28. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely low-birth-weight infants. N Engl J Med 2001; 344: 1966–1972.
29. Clyman R, Saha S, Jobe A, Oh W. Indomethacin prophylaxis for pre term infants: The impact of 2 multi-center randomized controlled trials on clinical practice. J Pediatr 2007; 150: 46–50.
30. Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwe´ W, Jespers A et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1945–1949.
31. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005; 164: 135–140.
32. Ment LR, Vohr B, Allen W, Westerveld M, Sparrow SS, Schneider KC et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2000; 105: 485–491.
33. Ment LR, Vohr BR, Makuch RW, Westerveld M, Katz KH, Schneider KC et al. Prevention of intraventricular hemorrhage by indomethacin in male preterm infants. J Pediatr 2004; 145: 832–834.
34. Aranda JV, Thomas R. Systematic review: intravenous ibuprofen in preterm newborns. Semin Perinatol 2006; 30: 114–120.
35. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfield CR. Prevalence of spontaneous closure of the ductus arteriosus in the neonates at a birth weight ofgrams or less. Pediatrics 2006; 4: 1113–1121.